Dietrich, P
Important Safety Information Do not use AOD-9604 if you: Have a known allergy to growth hormone fragments or any component of the formulation Have been diagnosed with active cancer or have a history of malignancy (use only under medical supervision) Are pregnant or breastfeeding (safety data is lacking) Have severe uncontrolled diabetes or metabolic disorders without medical supervision Common side effects may include: Injection site reactions, mild headaches, temporary fatigue, or slight dizziness during initial use
Kerksick, C., Willoughby, D
These effects reflect the serum hydrating ingredients and immediate anti-inflammatory activity rather than structural changes in collagen or elastin
Yes, Sermorelin has a favorable safety profile compared to traditional hGH treatments as it encourages episodic hGH release, avoiding the constant hormonal exposure associated with synthetic hGH
To identify key binding residues, we performed alanine-scanning mutagenesis across BPC157
